ALTSTATION.IO

Bunge Global SA (BG) Stock Analysis

By Nova Skye | AltStation.io | Updated September 29, 2026

Price
$109.28
Change
+0.26%
Market Cap
$20.99B
Avg Volume
1.6M

Company Overview

Bunge Global SA is an agribusiness giant that buys, processes, and moves crops worldwide. Headquartered in Chesterfield, Missouri, the company operates in the Farm Products industry within the Consumer Defensive sector. Its core business runs across four operating segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. Bunge buys raw crops like soybeans, softseeds, corn, wheat, barley, cotton, pulses, and sugar, converting them into milled grains, specialty oilseed goods, fertilizer, and biodiesel. It sells these finished commodities directly to buyers across the food manufacturing, animal feed, and biofuel industries.

Founded in 1818, Bunge operates as an entrenched market leader with a massive global footprint rather than a niche player. Its competitive edge lies in end-to-end infrastructure control, managing everything from grain elevators and processing plants to ocean freight and distribution. That integrated network lets Bunge extract value at multiple stages of the supply chain, whether supplying bulk meal to feed producers or refining softseed oils. The main operational threat is margin compression from volatile crop cycles, freight bottlenecks, and shifting commodity pricing across global markets.

Right now, Bunge is bridging traditional agricultural supply chains with industrial renewable energy. The company has tied its processing footprint to the energy transition, producing biodiesel directly through both its soybean and softseed divisions. At the same time, its merchandising and milling unit keeps volume moving through staple commodities like wheat, sugar, and corn while providing integrated trade financing and ocean logistics. By maintaining four distinct processing and merchandising divisions, Bunge stays balanced against individual crop shocks while expanding its reach into higher-margin refined products.

Key Financials
Market Cap
$20.99B
Revenue
$91.82B
EBITDA
$3.13B
Gross Margin
4.9%
Profit Margin
1.1%
Revenue Growth
88.3%
Total Cash
$788.00M
Total Debt
$17.06B
Free Cash Flow
-$6.48B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
23.55
Forward P/E
9.70
Beta
0.66
52-Week High
$134.87
52-Week Low
$79.11
EPS
$4.64
50-Day Avg
$115.16
200-Day Avg
$115.77
Price/Book
1.32
BG 52-Week Stock Chart
Technical Analysis
BG trades at $109.28, 56% of the way from its $77.13 52-week low to its $134.02 high. The stock is 18.63% below that high but remains 41.39% above the low. Price sits 7.21% below the 20-day moving average of $117.54. Momentum is negative, with declines of 3.15% over five trading days and 5.56% over 20 trading days. Near-term support is $109.00, while resistance stands at $124.59.


Recent News and Developments

Bunge will process BASF’s new canola hybrid

BASF and Bunge announced on September 22 that Bunge will process InVigor Gold canola seed, beginning at its Warden, Washington facility. BASF plans to launch the heat- and drought-tolerant hybrid in Montana, North Dakota and Washington in 2027. Source: Bunge

CME approves Bunge’s Wichita sorghum facility

CME Group approved Bunge USA Grain’s Wichita, Kansas facility for sorghum regularity on September 24. The approval took effect immediately and covers maximum capacity of 30,542,000 bushels. Source: CME Group

BG shares finish the week under pressure

BG fell 2.32% to $110.00 on September 22, rebounded 1.35% the next day, then declined 1.14% and 1.10% on September 24 and September 25. The stock closed September 28 at $109.06 after gaining 0.06% that session. Source: StockAnalysis.com



Market Sentiment and Analyst Recommendations

Bull Case
Bunge generated $91.82 billion in revenue, with reported revenue growth of 88.3%. That scale is substantial relative to its $20.99 billion market capitalization. Nine analysts rate BG a buy, with a $141.78 target versus the current $109.28 price. Even the bottom of the target range, $116.00, is above the current price, while the high estimate reaches $155.00. Bunge’s agreement to process BASF’s InVigor Gold canola seed provides a specific future catalyst tied to the hybrid’s planned 2027 launch. CME Group’s approval of the Wichita sorghum facility, covering 30,542,000 bushels of maximum capacity, also strengthens the case that Bunge’s processing infrastructure remains strategically useful.
Bear Case
The balance sheet is the clearest concern: Bunge holds $788.00 million in cash against $17.06 billion in total debt. That debt load leaves less room for operational mistakes or weaker business conditions. The stock also trades at 23.55 times earnings, so buyers are paying a meaningful multiple despite weak short-term price action. BG is 7.21% below its 20-day moving average and has lost 5.56% over the past 20 trading days. The current $109.28 price is barely above the $109.00 near-term support level, putting the stock close to a technical test. Analyst targets are positive, but the wide $116.00-to-$155.00 range shows substantial disagreement about the upside.
What to Watch
The first threshold is $109.00, the 30-day low and current near-term support level. A recovery above the $117.54 20-day moving average would improve the short-term technical picture. The next major test is $124.59, the 30-day high and stated near-term resistance. Investors should monitor whether the Wichita facility benefits from CME approval, which took effect September 24 and covers 30,542,000 bushels of maximum capacity. Bunge’s preparations to process BASF’s InVigor Gold canola seed also matter ahead of BASF’s planned 2027 launch in Montana, North Dakota and Washington. Over the next quarter, the thesis strengthens if negative five-day and 20-day momentum reverses; continued trading below the moving average would keep the technical setup weak.
Analyst Consensus
BUY

Based on 9 analyst opinions
Low Target
$116.00
Mean Target
$141.78
High Target
$155.00


Earnings and Financial Data

Sector
Consumer Defensive
Industry
Farm Products
Employees
34,000
Earnings & Dividends
Next Earnings
Nov 04, 2026
EPS (Trailing)
$4.64
Dividend Yield
264.0%
Payout Ratio
60.8%

Frequently Asked Questions

Is BG a good stock to buy?
Nine analysts recommend buying BG, and their average target is $141.78 versus a current price of $109.28. The takeaway is that analyst sentiment is bullish, although the stock’s short-term momentum is negative.
What is BG’s price target?
The average analyst target is $141.78, with estimates ranging from $116.00 to $155.00. The takeaway is that every listed target is above the current $109.28 price.
Is BG stock undervalued?
BG trades at a P/E ratio of 23.55 and has a market capitalization of $20.99 billion. The takeaway is that the provided data does not establish whether that valuation is cheap relative to peers.
What are BG’s support and resistance levels?
Near-term support is $109.00, and near-term resistance is $124.59. The takeaway is that the current $109.28 price is close to support.
Does BG pay a dividend?
The provided data does not include a dividend amount or yield. The takeaway is that investors should not assume a dividend from this dataset.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated September 29, 2026.